Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Alpine Immune Sciences by Quarter
Alpine Immune Sciences — Stock-based compensation expense ($M) ($M)
Vertex Pharmaceuticals Alpine Immune Sciences: $3.99M in Q1 2024, up 56.5% from a year earlier. That is the highest of the 25 quarters on record here. No newer figure appears in the documents we track.
Where the Q1 2024 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001626199 Alpine Immune Sciences).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Alpine Immune Sciences — Stock-based compensation expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2024 | Mar 31, 2024 | 3.99 | +56.5% | SEC Filing ↗ |
| Q4 2023 | Dec 31, 2023 | 2.81 | +13.3% | SEC Filing ↗ |
| Q3 2023 | Sep 30, 2023 | 2.65 | +3.9% | SEC Filing ↗ |
| Q2 2023 | Jun 30, 2023 | 2.62 | +12.4% | SEC Filing ↗ |
| Q1 2023 | Mar 31, 2023 | 2.55 | +11.4% | SEC Filing ↗ |
| Q4 2022 | Dec 31, 2022 | 2.48 | +69.9% | SEC Filing ↗ |
| Q3 2022 | Sep 30, 2022 | 2.55 | +55.5% | SEC Filing ↗ |
| Q2 2022 | Jun 30, 2022 | 2.33 | +51.3% | SEC Filing ↗ |
| Q1 2022 | Mar 31, 2022 | 2.29 | +43.1% | SEC Filing ↗ |
| Q4 2021 | Dec 31, 2021 | 1.46 | +53.7% | SEC Filing ↗ |
| Q3 2021 | Sep 30, 2021 | 1.64 | +69.1% | SEC Filing ↗ |
| Q2 2021 | Jun 30, 2021 | 1.54 | +25.2% | SEC Filing ↗ |
| Q1 2021 | Mar 31, 2021 | 1.60 | +61.6% | SEC Filing ↗ |
| Q4 2020 | Dec 31, 2020 | 0.95 | +20.3% | SEC Filing ↗ |
| Q3 2020 | Sep 30, 2020 | 0.97 | +18.3% | SEC Filing ↗ |
| Q2 2020 | Jun 30, 2020 | 1.23 | +80.9% | SEC Filing ↗ |
| Q1 2020 | Mar 31, 2020 | 0.99 | +32.0% | SEC Filing ↗ |
| Q4 2019 | Dec 31, 2019 | 0.79 | +6.8% | SEC Filing ↗ |
| Q3 2019 | Sep 30, 2019 | 0.82 | +51.9% | SEC Filing ↗ |
| Q2 2019 | Jun 30, 2019 | 0.68 | +30.8% | SEC Filing ↗ |
| Q1 2019 | Mar 31, 2019 | 0.75 | +47.1% | SEC Filing ↗ |
| Q4 2018 | Dec 31, 2018 | 0.74 | – | SEC Filing ↗ |
| Q3 2018 | Sep 30, 2018 | 0.54 | – | SEC Filing ↗ |
| Q2 2018 | Jun 30, 2018 | 0.52 | – | SEC Filing ↗ |
| Q1 2018 | Mar 31, 2018 | 0.51 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Alpine Immune Sciences ($M), quarterly Q1 2018–Q1 2024 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/alpine-sbc-exp
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.